Amber Pharmaceuticals (603087.SH) shareholder Xute Hongda has completed a reduction of 1% of its shares.

Zhitong Finance and Economics APP News, Ganli Pharmaceutical (603087.SH) announced that the company's shareholder Beijing Xute Hongda Technology Co., Ltd. (referred to as "Xute Hongda") has cumulatively reduced its holdings by 6.01 million shares through centralized bidding from April 22, 2025 to April 30, 2025, accounting for 1.00% of the company's total share capital. The reduction plan has been completed.